195 related articles for article (PubMed ID: 23465372)
1. Gefitinib enhances the efficacy of photodynamic therapy using 5-aminolevulinic acid in malignant brain tumor cells.
Sun W; Kajimoto Y; Inoue H; Miyatake S; Ishikawa T; Kuroiwa T
Photodiagnosis Photodyn Ther; 2013 Feb; 10(1):42-50. PubMed ID: 23465372
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines.
Mansi M; Howley R; Chandratre S; Chen B
Biochem Pharmacol; 2022 Jun; 200():115031. PubMed ID: 35390338
[TBL] [Abstract][Full Text] [Related]
3. Pivotal roles of peptide transporter PEPT1 and ATP-binding cassette (ABC) transporter ABCG2 in 5-aminolevulinic acid (ALA)-based photocytotoxicity of gastric cancer cells in vitro.
Hagiya Y; Endo Y; Yonemura Y; Takahashi K; Ishizuka M; Abe F; Tanaka T; Okura I; Nakajima M; Ishikawa T; Ogura S
Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):204-14. PubMed ID: 22959800
[TBL] [Abstract][Full Text] [Related]
4. Experimental use of photodynamic therapy in high grade gliomas: a review focused on 5-aminolevulinic acid.
Tetard MC; Vermandel M; Mordon S; Lejeune JP; Reyns N
Photodiagnosis Photodyn Ther; 2014 Sep; 11(3):319-30. PubMed ID: 24905843
[TBL] [Abstract][Full Text] [Related]
5. Low-dose arsenic trioxide enhances 5-aminolevulinic acid-induced PpIX accumulation and efficacy of photodynamic therapy in human glioma.
Wang C; Chen X; Wu J; Liu H; Ji Z; Shi H; Gao C; Han D; Wang L; Liu Y; Yang G; Fu C; Li H; Zhang D; Liu Z; Li X; Yin F; Zhao S
J Photochem Photobiol B; 2013 Oct; 127():61-7. PubMed ID: 23962849
[TBL] [Abstract][Full Text] [Related]
6. 5-Aminolevulinic acid-mediated photodynamic therapy can target human glioma stem-like cells refractory to antineoplastic agents.
Fujishiro T; Nonoguchi N; Pavliukov M; Ohmura N; Kawabata S; Park Y; Kajimoto Y; Ishikawa T; Nakano I; Kuroiwa T
Photodiagnosis Photodyn Ther; 2018 Dec; 24():58-68. PubMed ID: 29990642
[TBL] [Abstract][Full Text] [Related]
7. Critical role of ABCG2 in ALA-photodynamic diagnosis and therapy of human brain tumor.
Ishikawa T; Kajimoto Y; Inoue Y; Ikegami Y; Kuroiwa T
Adv Cancer Res; 2015; 125():197-216. PubMed ID: 25640271
[TBL] [Abstract][Full Text] [Related]
8. Calcitriol enhances 5-aminolevulinic acid-induced fluorescence and the effect of photodynamic therapy in human glioma.
Chen X; Wang C; Teng L; Liu Y; Chen X; Yang G; Wang L; Liu H; Liu Z; Zhang D; Zhang Y; Guan H; Li X; Fu C; Zhao B; Yin F; Zhao S
Acta Oncol; 2014 Mar; 53(3):405-13. PubMed ID: 24032442
[TBL] [Abstract][Full Text] [Related]
9. ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells.
Müller P; Abdel Gaber SA; Zimmermann W; Wittig R; Stepp H
J Photochem Photobiol B; 2020 Sep; 210():111963. PubMed ID: 32795847
[TBL] [Abstract][Full Text] [Related]
10. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
11. Enhancing the effect of 5-aminolevulinic acid based photodynamic therapy in human meningioma cells.
Cornelius JF; Slotty PJ; El Khatib M; Giannakis A; Senger B; Steiger HJ
Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):1-6. PubMed ID: 24486853
[TBL] [Abstract][Full Text] [Related]
12. Novel potential photodynamic therapy strategy using 5-Aminolevulinic acid for ovarian clear-cell carcinoma.
Teshigawara T; Mizuno M; Ishii T; Kitajima Y; Utsumi F; Sakata J; Kajiyama H; Shibata K; Ishizuka M; Kikkawa F
Photodiagnosis Photodyn Ther; 2018 Mar; 21():121-127. PubMed ID: 29196245
[TBL] [Abstract][Full Text] [Related]
13. Effects of ALA-mediated photodynamic therapy on the invasiveness of human glioma cells.
Hirschberg H; Sun CH; Krasieva T; Madsen SJ
Lasers Surg Med; 2006 Dec; 38(10):939-45. PubMed ID: 17163479
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of aminolevulinic acid-mediated protoporphyrin IX fluorescence and enhancement by ABCG2 inhibitors in renal cell carcinoma cells.
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
J Photochem Photobiol B; 2020 Oct; 211():112017. PubMed ID: 32919173
[TBL] [Abstract][Full Text] [Related]
15. Minimally invasive photodynamic therapy (PDT) for ablation of experimental rat glioma.
Hirschberg H; Spetalen S; Carper S; Hole P; Tillung T; Madsen S
Minim Invasive Neurosurg; 2006 Jun; 49(3):135-42. PubMed ID: 16921452
[TBL] [Abstract][Full Text] [Related]
16. Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy.
Chandratre S; Olsen J; Howley R; Chen B
Biochem Pharmacol; 2023 Nov; 217():115851. PubMed ID: 37858868
[TBL] [Abstract][Full Text] [Related]
17. Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer.
Hagiya Y; Fukuhara H; Matsumoto K; Endo Y; Nakajima M; Tanaka T; Okura I; Kurabayashi A; Furihata M; Inoue K; Shuin T; Ogura S
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):288-95. PubMed ID: 23993855
[TBL] [Abstract][Full Text] [Related]
18. Improvement of the efficacy of 5-aminolevulinic acid-mediated photodynamic treatment in human oral squamous cell carcinoma HSC-4.
Yamamoto M; Fujita H; Katase N; Inoue K; Nagatsuka H; Utsumi K; Sasaki J; Ohuchi H
Acta Med Okayama; 2013; 67(3):153-64. PubMed ID: 23804138
[TBL] [Abstract][Full Text] [Related]
19. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.
Palasuberniam P; Yang X; Kraus D; Jones P; Myers KA; Chen B
Sci Rep; 2015 Aug; 5():13298. PubMed ID: 26282350
[TBL] [Abstract][Full Text] [Related]
20. Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.
Palasuberniam P; Kraus D; Mansi M; Howley R; Braun A; Myers K; Chen B
J Biomed Opt; 2021 Sep; 26(9):. PubMed ID: 34545713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
